GEVA

Synageva BioPharma Corp. News Headlines

$64.8
*  
0.23
0.36%
Get GEVA Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading GEVA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Synageva Slips on Wider-than-Expected Q2 Loss - Analyst Blog
8/1/2014 4:30:00 PM - Zacks.com

Thursday's ETF Movers: BSCF, XBI
7/31/2014 1:38:01 PM - BNK Invest

Sector Update: Health Care
7/18/2014 1:33:31 PM - MT Newswires

Sector Update: Health Care Stocks Following Broader Markets Highers; GlycoMimetics Jumps More Than 10% After Naming Cancer-Specialist to Board
7/18/2014 1:32:37 PM - MT Newswires

ACADIA Pharma Appoints Stephen Davis As CFO - Quick Facts
7/15/2014 9:17:00 AM - RTT News

Synageva's Sebelipase Alfa Meets Primary Endpoint in ARISE - Analyst Blog
7/1/2014 4:00:00 PM - Zacks.com

Synageva's Q1 Loss Narrower than Expected - Analyst Blog
5/1/2014 5:10:01 PM - Zacks.com

Synageva Heading For Big Disappointment
4/22/2014 11:05:00 AM - Seeking Alpha

Synageva Heading For Big Disappointment
4/22/2014 10:00:00 AM - Seeking Alpha

Synageva Heading For Big Disappointment
4/22/2014 10:00:00 AM - SeekingAlpha

Synageva 4Q Loss Narrower-than-Expected Loss - Analyst Blog
3/4/2014 12:00:01 PM - Zacks.com

After-Hours Earnings Report for March 3, 2014 : SCTY, VIPS, GWRE, GEVA, URS, MR, ASNA, MDR, NUVA, DXPE, MCP, AUQ
3/3/2014 3:00:01 PM - NASDAQ.com News

Synageva BioPharma Corp. (GEVA) in Focus: Stock Moves 5.1% Higher - Tale of the Tape
2/20/2014 10:21:01 AM - Zacks.com

Will Synageva (GEVA) Continue to Surge Higher? - Tale of the Tape
1/29/2014 8:27:01 AM - Zacks.com

Patients Enrolled in Synageva Study - Analyst Blog
1/7/2014 5:15:01 PM - Zacks.com

Orphan Drug Designations: Why You Should Care
12/12/2013 10:23:00 AM - Seeking Alpha

Synageva Progresses with Sebelipase Alpha - Analyst Blog
12/4/2013 12:06:23 PM - Zacks.com

Synageva: A Strong Candidate For Your Portfolio
10/8/2013 2:01:00 PM - Seeking Alpha

Synageva Raises Funds - Analyst Blog
10/1/2013 5:47:36 PM - Zacks.com

Insiders at Synageva BioPharma and Bind Therapeutics Buy Shares
9/30/2013 10:12:00 AM - Minyanville

Synageva Prices Public Offering - Analyst Blog
9/25/2013 5:05:01 PM - Zacks.com

Sector Update: Healthcare Stocks Flat in Pre-Market; Syngeva Prices Public Offering
9/25/2013 8:00:52 AM - MT Newswires

Sector Update: Healthcare
9/25/2013 8:00:05 AM - MT Newswires

What Does The FDA's Breakthrough Designation Mean For Investors?
8/26/2013 12:45:00 PM - Seeking Alpha

FDA Designation for Synageva Candidate - Analyst Blog
5/22/2013 4:27:38 PM - Zacks.com